FDA advisers endorse bivalent vaccine for all COVID mRNA shots
By
Alicia Lasek
Jan 27, 2023
A panel of experts on Thursday agreed that the bivalent COVID-19 vaccines should be used as both initial and booster shots, phasing out the original vaccines.
To reach unvaccinated, U.S. secures 3.2M doses of Novavax vaccine
By
Liza Berger
Jul 12, 2022
Pending authorization by the Food and Drug Administration, the federal government has secured 3.2 million cases of Novavax’s COVID-19 vaccine.